Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-28 Sale |
2024-03-01 06:45 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
9,815 | $13.12 | $128,734 | 9,701 (Direct) |
View |
| 2024-02-28 Sale |
2024-03-01 06:43 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,599 | $13.12 | $270,176 | 69,770 (Direct) |
View |
| 2024-02-28 Sale |
2024-03-01 06:40 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" |
1,366 | $13.12 | $17,916 | 2,928 (Direct) |
View |
| 2024-02-16 Sale |
2024-02-21 07:37 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
173,261 | $13.05 | $2,261,905 | 1 (Direct) |
View |
| 2024-02-15 Sale |
2024-02-20 07:42 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO |
74,530 | $13.15 | $980,174 | 410,436 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-05 07:49 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
31,766 | $12.37 | $392,955 | 10,676 (Direct) |
View |
| 2023-08-07 Sale |
2023-08-09 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
35,125 | $9.7335 | $341,889 | 99,162 (Direct) |
View |
| 2023-08-04 Sale |
2023-08-07 4:15 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
1,981 | $9.921 | $19,658 | 42,442 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-04 Option Award |
2024-03-05 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
74,404 | $0 | 616,822 (Direct) |
View |
| 2024-03-03 Exercise |
2024-03-05 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
58,412 | $0 | 616,822 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-05 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
93,005 | $0 | 682,095 (Direct) |
View |
| 2024-03-03 Exercise |
2024-03-05 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
83,312 | $0 | 682,095 (Direct) |
View |
| 2024-03-04 Option Award |
2024-03-05 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
22,600 | $0 | 89,243 (Direct) |
View |
| 2024-03-03 Exercise |
2024-03-05 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
15,855 | $0 | 89,243 (Direct) |
View |
| 2024-02-28 Exercise |
2024-03-01 06:57 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Bergwerk Dov Acting Chief Legal Officer |
6,653 | $0 | 96,983 (Direct) |
View |
| 2024-02-28 Exercise |
2024-03-01 06:54 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
18,430 | $0 | 124,222 (Direct) |
View |
| 2024-02-28 Exercise |
2024-03-01 06:52 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
20,599 | $0 | 342,281 (Direct) |
View |
| 2024-02-28 Exercise |
2024-03-01 06:48 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
3,219 | $0 | 13,895 (Direct) |
View |
| 2024-02-28 Exercise |
2024-03-01 06:45 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
19,515 | $0 | 9,701 (Direct) |
View |
| 2024-02-28 Exercise |
2024-03-01 06:43 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
20,599 | $0 | 69,770 (Direct) |
View |
| 2024-02-28 Exercise |
2024-03-01 06:40 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" |
4,294 | $0 | 2,928 (Direct) |
View |
| 2024-02-15 Exercise |
2024-02-20 07:42 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO |
161,655 | $0 | 410,436 (Direct) |
View |
| 2024-02-13 Exercise |
2024-02-15 07:37 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
6,630 | $0 | 105,792 (Direct) |
View |
| 2024-01-30 Option Award |
2024-02-01 07:28 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
55,226 | $0 | 55,226 (Direct) |
View |
| 2024-01-30 Option Award |
2024-02-01 07:26 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
52,320 | $0 | 52,320 (Direct) |
View |
| 2024-01-30 Option Award |
2024-02-01 07:22 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
55,226 | $0 | 55,226 (Direct) |
View |
| 2024-01-30 Option Award |
2024-02-01 07:18 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
58,133 | $0 | 58,133 (Direct) |
View |
| 2023-11-20 Option Award |
2023-11-22 07:18 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial |
253,968 | $0 | 253,968 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-16 07:36 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" |
33,482 | $0 | 33,482 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-16 07:35 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Bergwerk Dov Acting Chief Legal Officer |
33,482 | $0 | 33,482 (Direct) |
View |
Ownership |
2023-10-18 07:15 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Bergwerk Dov Acting Chief Legal Officer |
0 | $0 | 268,460 (Direct) |
View |
Ownership |
2023-10-05 07:20 am |
N/A 2024-03-12 |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Conway Vikki L See "Remarks" |
0 | $0 | 114,628 (Direct) |
View |
| 2023-09-02 Option Award |
2023-09-05 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shalev Varda Director |
12,872 | $0 | 12,872 (Direct) |
View |
| 2023-08-09 Option Award |
2023-08-10 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Grant Angus EVP, Business Development |
51,652 | $0 | 51,652 (Direct) |
View |
| 2023-08-04 Exercise |
2023-08-07 4:12 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director |
15,810 | $0 | 28,032 (Direct) |
View |
| 2023-08-04 Exercise |
2023-08-07 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director |
15,810 | $0 | 42,957 (Direct) |
View |
| 2023-08-04 Exercise |
2023-08-07 4:09 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director |
15,810 | $0 | 67,169 (Direct) |
View |
| 2023-08-04 Exercise |
2023-08-07 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director |
15,810 | $0 | 74,575 (Direct) |
View |
| 2023-08-04 Exercise |
2023-08-07 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director |
15,810 | $0 | 3,074,575 (Direct) |
View |
| 2023-08-04 Exercise |
2023-08-07 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director |
15,810 | $0 | 84,917 (Direct) |
View |
| 2023-08-04 Exercise |
2023-08-07 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director |
15,810 | $0 | 2,073,223 (Direct) |
View |
| 2023-08-04 Exercise |
2023-08-07 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director |
15,810 | $0 | 82,507 (Direct) |
View |
| 2023-08-04 Exercise |
2023-08-07 4:02 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director |
28,162 | $0 | 371,516 (Direct) |
View |